Twelve gene therapies have been approved by the FDA to date to treat a variety of diseases, including the first ever gene edited therapeutic. The CMC package required to effectively demonstrate safety and efficacy of increasingly complex gene therapy products to regulators needs to keep pace.
The 6th Gene Therapy Analytical Development & CMC Summit will unite 250+ analytical development, CMC, QC, and process development experts to showcase innovative analytical and process development methods, assess their readiness, and ultimately guarantee safety, quality, efficacy, and consistency of gene therapies to regulators.
Event Name: 6th Gene Therapy Analytical Development & CMC Summit
Event Date: October 30 – November 1
Event Venue: The Westin Copley Place, 10 Huntington Ave, Boston, MA 02116, United States
Event Organizers: Hanson Wade
Email: General Enquiries: info@hansonwade.com or Partnership Enquiries: sponsor@hansonwade.com